Insights

Strategic Merger Sunovion is undergoing a consolidation with Sumitomo Pharma America after merging seven U.S. subsidiaries, signaling a broader corporate footprint and potential access to enhanced resources, distribution channels, and cross-sell opportunities for portfolio alignment.

Phase 3 Collaboration The partnership with PsychoGenics to develop Ulotaront for schizophrenia indicates ongoing late-stage R&D activity and potential future licensing or co-promotion opportunities around novel antipsychotics.

Major Product Transition LATUDA exclusivity loss has driven strategic restructuring; this creates openings for portfolio shifts, EDAs, and partnerships to fill competitive gaps or accelerate launches of alternative therapies.

Digital & ERP Readiness Adoption of Salesforce, SAP Ariba, Oracle E-Business Suite, Tableau, and other modern tech indicates strong data, procurement, and sales enablement capabilities that can be leveraged to streamline partner onboarding and channel collaborations.

Cost & Growth Signals Recent headcount reductions paired with revenue in a $1B–$10B band suggest a focus on efficiency and potential opportunities to offer services or products that support cost optimization, manufacturing scalability, and market expansion post-merger.

Similar companies to Sunovion Pharmaceuticals

Daiichi Sankyo Japan
1.9K$1B - $10B
Lundbeck
6K$1B - $10B
Astellas Pharma
13K$10B+
Glenmark Pharmaceuticals
16K$1B - $10B
Intra-Cellular Therapies
559$500M - $1B

Sunovion Pharmaceuticals Tech Stack

Sunovion Pharmaceuticals uses 8 technology products and services including Qlik, Tableau, Contentful, and more. Explore Sunovion Pharmaceuticals's tech stack below.

Qlik
Business Intelligence
Tableau
Business Intelligence
Contentful
Content Management System
Salesforce
Customer Relationship Management
Oracle E-Business Suite
Enterprise Resource Planning
Azure Active Directory
Identity And Access Management
Microsoft Azure
Platform As A Service
SAP Ariba
Procurement

Media & News

Sunovion Pharmaceuticals's Email Address Formats

Sunovion Pharmaceuticals uses at least 4 email formats:

Sunovion Pharmaceuticals Email Formats	Example	Percentage
First.Last@sunovion.com	John.Doe@sunovion.com	90%
FLast@sunovion.com	JDoe@sunovion.com	6%
Last.First@sunovion.com	Doe.John@sunovion.com	3%
First.Middle@sunovion.com	John.Michael@sunovion.com	1%

Frequently Asked Questions

What is Sunovion Pharmaceuticals's phone number?

You can contact Sunovion Pharmaceuticals's main corporate office by phone at

+1-201-592-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Sunovion Pharmaceuticals's stock symbol?

Sunovion Pharmaceuticals is a publicly traded company; the company's stock symbol is SEPR.

What is Sunovion Pharmaceuticals's official website and social media links?

Sunovion Pharmaceuticals's official website is sunovion.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Sunovion Pharmaceuticals generate?

As of October 2026, Sunovion Pharmaceuticals's annual revenue is estimated to be $1B - $10B.

What is Sunovion Pharmaceuticals's NAICS code?

Sunovion Pharmaceuticals's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Sunovion Pharmaceuticals have currently?

As of October 2026, Sunovion Pharmaceuticals has approximately 906 employees across 4 continents, including North America, Europe and Asia. Key team members include Chief Executive Officer: J. O., Chief Information Officer, Vice President Head Of It: E. K. and Head Of It Business Systems: C. R. Explore Sunovion Pharmaceuticals's employee directory with LeadIQ.

What industry does Sunovion Pharmaceuticals belong to?

Sunovion Pharmaceuticals operates in the Pharmaceutical Manufacturing industry.

What technology does Sunovion Pharmaceuticals use?

Sunovion Pharmaceuticals's tech stack includes Qlik, Tableau, Contentful, Salesforce, Oracle E-Business Suite, Azure Active Directory, Microsoft Azure and SAP Ariba.

What is Sunovion Pharmaceuticals's email format?

Sunovion Pharmaceuticals's email format typically follows the pattern of First.Last@sunovion.com. Find more Sunovion Pharmaceuticals email formats with LeadIQ.

When was Sunovion Pharmaceuticals founded?

Sunovion Pharmaceuticals was founded in 2010.

Sunovion Pharmaceuticals

Q: What is Sunovion Pharmaceuticals's official website and social media links?

Sunovion Pharmaceuticals's official website is sunovion.com. Sunovion Pharmaceuticals has social profiles on LinkedIn.

Q: How many employees does Sunovion Pharmaceuticals have currently?

Sunovion Pharmaceuticals has approximately 906 employees.

Q: What technology does Sunovion Pharmaceuticals use?

Sunovion Pharmaceuticals's tech stack includes R Project, SAS, Microsoft Office, OAuth, Microsoft 365.

Q: What is Sunovion Pharmaceuticals's NAICS code?

Sunovion Pharmaceuticals's NAICS code is 3254 (Pharmaceutical and Medicine Manufacturing).

Pharmaceutical ManufacturingUnited States501-1000 Employees

Sepracor is a United States-based pharmaceutical manufacturing company. It employs between 501 and 1000 people and maintains a web presence at sunovion.com. The company is described as having transitioned to Sumitomo Pharma America (SMPA). In 2023, Sumitomo Pharma merged its U.S. subsidiaries with Sunovion Pharmaceuticals Inc., consolidating into a single U.S. entity with Sunovion as the remaining company, reflecting the corporate restructuring described in the provided information. Related activities within the broader Sunovion/SMPA network include collaborations and product launches such as a partnership with PsychoGenics on Ulotaront for schizophrenia, and Gemtesa's launch in the U.S., indicating ongoing pharmaceutical development and commercialization work within the group.